New research by Global Action Plan, coinciding with this year's Clean Air Day, 21 June, found that primary and nursery school children were being exposed to 30% more toxic pollution compared to adults when walking along busy roads
Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explains why air matters, for everybody, everywhere (H2)
NHS England’s Diabetes Prevention Programme is placed under the spotlight by Open Access Government
Over the last few years, it has been discovered that too many patients are being treated as if they were emergencies. Is it all bad for the organisation though? Join Tilly Bailey & Irvine Law Firm as they weigh up both the positive and negative aspects of the NHS
The Prime Minister has announced that the NHS will receive increased funding of £20.5 billion per year by the end of five years
Prof. Martin Schrappe, President of the European Society for Paediatric Oncology details the vital role of collaboration in tackling paediatric cancer across Europe
Amanda White, Director of Communications and Marketing at Health Data Research UK, reflects on the opportunities to harness the UK’s strengths in data science to transform health
Helen McShane, Professor of Vaccinology at The Jenner Institute, University of Oxford reveals the current status of tuberculosis vaccine development in the world today.
Boris Šustaršič, President of the European Alliance of Neuromuscular Disorders Associations shares his thoughts on the key issues around muscular dystrophy (MD) in Europe today
Jonathan Evans, communications manager at the Association of British HealthTech Industries provides an interesting update on the health technology sector, including the extent to which the UK exports to the EU every year in this vein.
Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.
Shyh-Jye Lee (Jeff), Ph. D, President of the Taiwanese Society of Developmental Biology (TSDB) explains the way in which developmental biology impacts upon our lives
Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
Marcin Rodzinka, Project Coordinator at Mental Health Europe explains how transparency between the pharma industry and health professionals can influence the quality of mental health care in Europe today
Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children
Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention
Mary Hartshorne, I CAN’s Head of Evidence shares her thoughts on the report Bercow: Ten Years On and the next steps for children and young people with speech, language and communication needs
Prof Colin J Suckling OBE DSc FRSE, research professor of chemistry at the University of Strathclyde’s Department of Pure & Applied Chemistry shares his views on the challenge of commercialisation when it comes to research into medicinal chemistry
Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
Kristoffer From, CEO of Liva Healthcare and Simon Pickup, UK Managing Director at Liva Healthcare share their thoughts on why obesity is key to tackling the root cause of Type 2 diabetes